Project Grant 2537968
- The National Science Foundation (NSF) awarded a $305,000 STTR Phase I project grant to Sensvita Inc. under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a non-invasive radio frequency sensing technology for home-based monitoring of heart and lung function. The proposed system uses advanced sensing methods to measure critical physiological parameters without the need for skin contact or maintenance, improving the convenience, scalability,...
- The National Science Foundation awarded Levosens, Inc., $305,000 on August 15, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an electrochemical biosensing platform integrating machine learning and multimodal electrochemical sensing for real-time biomarker detection. The recipient will address limitations of current biosensors by combining multiple electrochemical sensing modalities to improve signal quality, sensitivity, and analyte specificity...
- The National Science Foundation awarded Integrated Medical Sensors Inc. a $256,000 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a novel multi-analyte microsensor platform for continuous wireless monitoring applications. The grant aims to create a unique monolithic semiconductor platform capable of wirelessly monitoring multiple biochemical and physiological markers simultaneously in a sub-cubic millimeter footprint. This miniature,...
- The National Science Foundation awarded Xilior Technologies Inc. $305,000 on October 1, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a compact wristband interface for high-fidelity gesture recognition through distributed strain sensing, analog multiplexing, and edge machine learning. The Small Business Technology Transfer (STTR) Phase I project addresses human-computer interaction limitations by creating a wrist-worn device that enables users to...
- The National Science Foundation awarded AMG Detection, Inc. $305,000 on July 1, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a wearable carbon nanotube sensor array for seizure prediction. The project aims to create the first scalable, non-invasive wearable device capable of predicting epileptic seizures 10–45 minutes before onset by detecting a validated panel of nine pre-seizure volatile organic compounds emitted from the skin. Current seizure...
- The National Science Foundation (NSF) awarded a $550,000 Project Grant under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to the University of Missouri System to develop six-lead, wearable heart monitors using innovative, multifunctional, porous, soft materials. The project aims to enhance wearable heart monitors for improved cardiac health management by addressing current limitations in ambulatory ECG monitoring, such as motion-induced artifacts and limited...
- The National Science Foundation awarded Impulse Wellness LLC $304,997 on July 1, 2026, under the SBIR Fast-Track program to design and validate a wearable electromyography-based stroke rehabilitation system. The recipient will develop a sensor-embedded textile garment integrating reusable electrodes tailored to specific muscles and therapeutic activities, connected to built-in sensors to track muscle electrical activity during dynamic exercises and deliver real-time biofeedback. The system...
- The National Science Foundation Division of Electrical, Communications and Cyber Systems awarded $200,000 to the University of Houston on October 1, 2026, for collaborative research developing FBEP-enabled electrochemical sensors for heart failure monitoring under the Engineering program (CFDA 47.041). The research develops a wearable sensing approach for continuous monitoring of N-terminal pro-B-type natriuretic peptide in skin interstitial fluid as an alternative to intermittent blood draws...
- The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...
- The National Science Foundation awarded Trustees of Indiana University $278,045 under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) on December 1, 2025, for development of a parity-time-symmetric biotelemetry system enabling real-time, continuous wireless monitoring of physiological signs from battery-free implantable microsensors with high accuracy and unprecedented resolution. The project focuses on advancing wireless, implantable sensors for monitoring patients with...
The National Science Foundation awarded $304,950 to Senphonix, Inc. on October 1, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop injection-molded biosymbiotic devices for long-term, multimodal physiological monitoring as a Small Business Technology Transfer (STTR) Phase I project. The work centers on designing and demonstrating a lightweight mesh wearable sleeve with embedded microsensors, coupled with wireless charging electronics, remote radio communications, and a software-as-a-service system for data analysis and EHR integration. The sleeve uses human factors engineering to achieve user comfort and long-term wearability without adhesives or straps. The embedded sensors measure heart rate, respiration, temperature, and motion. The project aims to deliver clinical-grade wearables suitable for continuous monitoring, addressing current limitations of adhesive-based clinical wearables and consumer watch or ring form factors that cannot collect clinical-grade data from ideal physiological locations. The anticipated commercial impact includes automating vital sign measurement and documentation to free nursing time currently spent on manual vital sign collection, reduce hospital labor costs, and address nursing shortages and burnout. Performance occurs at Vadnais Heights, Minnesota. The period of performance runs from October 1, 2026, through September 30, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $305.0k | 8/13/26 |